CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Operating activities:
Net loss	$ (2,523)	$ (2,164)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of property and equipment	7	6
Amortization of other assets	162	90
Noncash stock-based compensation, including stock options and restricted stock	401	335
Noncash warrant inducement	14	0
Inventory reserve	5	0
Gain/(loss) on foreign currency transactions	17	(3)
Gain on sale of equipment	(3)	0
(Increase) decrease in operating assets:
Accounts receivable	831	852
Inventory	16	(47)
Prepaid expenses and other current assets	71	65
Increase (decrease) in operating liabilities:
Accounts payable and accrued expenses	(45)	286
License and supply agreement fee payable	(1,318)	0
Deferred revenue	(535)	(509)
Net cash used in operating activities	(2,900)	(1,089)
Investing activities:
Purchase of property and equipment		(7)
Proceeds from sale of equipment	3	0
Purchase of intangible assets	0	(659)
Net cash provided by (used in) investing activities	3	(666)
Financing activities:
Proceeds from exercise of warrants	248	451
Proceeds from issuance of Senior Secured Note	1,300	0
Proceeds from issuance of common stock, net of equity issuance costs of $229	2,771	0
Payment of Senior Secured Note	(1,300)	0
Net cash provided by financing activities	3,019	451
Effect of exchange rates on cash and cash equivalents	(1)	1
Net increase (decrease) in cash	121	(1,303)
Cash, beginning of period	47	1,669
Cash, end of period	168	366
Supplemental disclosure of cash flow information
Cash paid for taxes	2	18
Restricted stock issued to settle liability	116	0
Payable related to license and supply agreement	0	1,266
Receivable related to license agreement	0	771
Fair value of stock options granted to Medica	$ 0	$ 273